Common causes of postmenopausal bleeding include atrophy and fibroids. Learn about risk factors, treatments, and when to ...

Additional benefits seen for diastolic blood pressure and concentrations of triglycerides and aspartate aminotransferase.

Combining hormonal therapy and tirzepatide may lead to the greatest weight loss after menopause, new evidence suggests.

Experts explain the latest research.

Female brains have historically evolved to adapt to pregnancy, undergoing structural and functional changes. But the ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

A UK Biobank suggests hormone replacement therapy may offer only limited protection for mental health and cognition in ...

Researchers have found in a retrospective cohort study that postmenopausal women with obesity treated with tirzepatide ...

Postmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29 in JAMA Network Open. Yufan Liu and Chenglong Li, ...

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women. Hormone replacement therapy and early menarche are significant risk ...

Postmenopausal women score better on cognitive and memory tests if they have been pregnant or breastfed earlier in life, new ...

Dr. Jordan answers the question: 'How can I be estrogen receptor-positive?' — -- Question: How can my breast cancer be estrogen receptor-positive when I am postmenopausal and my body is losing ...